POLE and endometrial cancer: The broad histopathological classification of endometrial cancer also associates with molecular classifications identified by The Cancer Genome Atlas, where type I tumors fall largely into the copy-number low, microsatellite instable (MSI), and POLE mutated etiologies, while type II tumors are enriched for the copy-number high etiology and for TP53 mutations5–7.